CLASS III ONGOING Drug recall · Reported 22 Oct 2025 · FDA Enforcement Report

Ketamine Hydrochloride, 50mg/ (10mg/mL), Injection recalled

Staq Pharma is recalling Ketamine Hydrochloride, 50mg/ (10mg/mL), Injection for IV use syringe, STAQ Pharma Inc, distributed nationwide in the US. The recall was initiated on 9 Oct 2025 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 25156673A, Expiry: 02FEB2026.

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0024-2026
FDA event ID
97779
Recalling firm
Staq Pharma, Denver, CO
Classification
Class III
Status
Ongoing
Recall initiated
9 Oct 2025
FDA classified
15 Oct 2025
Reported
22 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

9 Oct 2025Recall initiated by company
15 Oct 2025Classified by FDA+6 days
22 Oct 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Product as listed by the FDA

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

Where it was distributed

Nationwide in the U.S.

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Incorrect or Missing Lot and/or Exp Date

Which lots are affected?

Lot #: 25156673A, Expiry: 02FEB2026.

Where was it sold?

Nationwide in the U.S.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 97779

More recalls from Staq Pharma

All 6

Other Ketamine recalls

All 37